CFND; CFNS; EFL3; EPLG2; Elk-L; LERK2; EPH-related receptor tyrosine kinase ligand 2; Craniofrontonasal Syndrome(Craniofrontonasal Dysplasia)
CFND; CFNS; EFL3; EPLG2; Elk-L; LERK2; EPH-related receptor tyrosine kinase ligand 2; Craniofrontonasal Syndrome(Craniofrontonasal Dysplasia)
CAPB; DRT; EPHT3; ERK; Hek5; PCBC; Tyro5; Developmentally-regulated Eph-related tyrosine kinase; ELK-related tyrosine kinase; EPH-like kinase 5; EPH tyrosine kinase 3
CAPB; DRT; EPHT3; ERK; Hek5; PCBC; Tyro5; Developmentally-regulated Eph-related tyrosine kinase; ELK-related tyrosine kinase; EPH-like kinase 5; EPH tyrosine kinase 3
ETK2; HEK2; TYRO6; EPH-like tyrosine kinase 2; Embryonic kinase 2; Tyrosine-protein kinase TYRO6
ETK2; HEK2; TYRO6; EPH-like tyrosine kinase 2; Embryonic kinase 2; Tyrosine-protein kinase TYRO6
ETK2; HEK2; TYRO6; EPH-like tyrosine kinase 2; Embryonic kinase 2; Tyrosine-protein kinase TYRO6
ETK2; HEK2; TYRO6; EPH-like tyrosine kinase 2; Embryonic kinase 2; Tyrosine-protein kinase TYRO6
ETK; ETK1; HEK; HEK4; TYRO4; Human embryo kinase; Tyrosine-protein kinase receptor ETK1
ETK; ETK1; HEK; HEK4; TYRO4; Human embryo kinase; Tyrosine-protein kinase receptor ETK1
LDH-C; CT32; LDHX; LDH3; Cancer/Testis Antigen 32; LDH testis subunit
LDH-C; CT32; LDHX; LDH3; Cancer/Testis Antigen 32; LDH testis subunit